ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
DAMORA THERAPEUT
28.10
+1.26
4.69%
盤後:
28.10
0.0000
0.00%
19:30 EDT
成交量:
52.54萬
成交額:
1,469.04萬
市值:
17.30億
市盈率:
-2.85
高:
28.53
開:
27.32
低:
26.87
收:
26.84
52周最高:
38.33
52周最低:
2.53
股本:
6,155.32萬
流通股本:
4,764.87萬
量比:
1.13
換手率:
1.10%
股息:
- -
股息率:
- -
每股收益(TTM):
-9.8764
每股收益(LYR):
-153.9532
淨資產收益率:
-99.74%
總資產收益率:
-21.61%
市淨率:
4.48
市盈率(LYR):
-0.18
資料載入中...
總覽
公司
新聞
公告
Damora Therapeutics啓動Dmr-001治療突變CALR驅動型原發性血小板增多症與骨髓纖維化的Clarity-101 1/1B期臨床試驗
美股速递
·
08/05
美國研究綜述-黑石集團、哈特福德保險公司、澤夫拉治療公司
路透中文
·
07/27
傑富瑞首次覆蓋Damora Therapeutics,給予買入評級,目標價50美元
美股速递
·
07/27
美國研究綜述-思科、DTE能源、美滿科技
路透中文
·
05/14
Galecto Inc旗下Damora計劃於2026年中提交DMR-001新藥臨床試驗申請 概念驗證數據預計2027年中公布
美股速递
·
03/09
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/DMRA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":28.1,"timestamp":1789156800000,"preClose":26.84,"halted":0,"volume":525410,"hourTrading":{"tag":"盘后","latestPrice":28.1,"preClose":28.1,"latestTime":"19:30 EDT","volume":10753,"amount":302160.02,"timestamp":1789169408731,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04694485842026831,"floatShares":47648701,"shares":61553200,"eps":-9.876431,"marketStatus":"休市中","change":1.26,"latestTime":"09-11 16:00:00 EDT","open":27.32,"high":28.53,"low":26.87,"amount":14690405.8049,"amplitude":0.061848,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.876431,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":26.84,"postHourTrading":{"tag":"盘后","latestPrice":28.1,"preClose":28.1,"latestTime":"19:30 EDT","volume":10753,"amount":302160.02,"timestamp":1789169408731,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1304901638039173},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","floatShares":47648701,"roa":"-21.61%","roe":"-99.74%","lyrEps":-153.953213,"volumeRatio":1.1304901638039173,"shares":61553200,"dividePrice":0,"high":28.53,"amplitude":0.061848,"preClose":26.84,"low":26.87,"week52Low":2.53,"pbRate":"4.48","week52High":38.3251,"institutionHeld":0,"latestPrice":28.1,"eps":-9.876431,"divideRate":0,"volume":525410,"delay":0,"ttmEps":-9.876431,"open":27.32,"prevYearClose":23.01,"prevWeekClose":30.06,"prevMonthClose":28.18,"prevQuarterClose":26.01,"fiveDayClose":28,"twentyDayClose":30.73,"sixtyDayClose":20.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"DMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2026-03-19","symbol":"DMRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"DMRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-2.36},{"market":"US","date":"2025-08-05","symbol":"DMRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-2.6},{"market":"US","date":"2025-05-08","symbol":"DMRA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.92}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1785124800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMRA","date":"2026-09-11","current":-2.845157,"percent":0.81746,"low":-100.260711,"twenty":-7.706597,"median":-7.187671,"eighty":-6.346489,"high":-5.207587,"avg":-12.339462,"sd":20.848416,"marketCap":1656981329},"quantilePoints":[{"date":"2026-03-13","current":-100.260711,"twenty":-100.260711,"median":-100.260711,"eighty":-98.29884,"marketCap":1588530698},{"date":"2026-03-20","current":-72.999835,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"marketCap":1156609382},{"date":"2026-03-27","current":-7.36551,"twenty":-98.861547,"median":-80.41388,"eighty":-7.003988,"marketCap":1545571323},{"date":"2026-04-02","current":-7.207452,"twenty":-96.587906,"median":-7.443103,"eighty":-7.019507,"marketCap":1512404556},{"date":"2026-04-10","current":-7.670132,"twenty":-94.238224,"median":-7.361199,"eighty":-7.021806,"marketCap":1609492728},{"date":"2026-04-17","current":-7.759219,"twenty":-89.113027,"median":-7.443103,"eighty":-7.088477,"marketCap":1628186724},{"date":"2026-04-24","current":-7.305161,"twenty":-78.931071,"median":-7.519258,"eighty":-7.200555,"marketCap":1532907649},{"date":"2026-05-01","current":-7.374132,"twenty":-59.951712,"median":-7.420112,"eighty":-7.071235,"marketCap":1547380419},{"date":"2026-05-08","current":-7.181588,"twenty":-7.748873,"median":-7.369821,"eighty":-7.098823,"marketCap":1506977267},{"date":"2026-05-15","current":-6.125513,"twenty":-7.702318,"median":-7.328151,"eighty":-6.979849,"marketCap":1440040702},{"date":"2026-05-22","current":-6.376895,"twenty":-7.679328,"median":-7.296539,"eighty":-6.874668,"marketCap":1499137850},{"date":"2026-05-29","current":-6.50384,"twenty":-7.670132,"median":-7.208889,"eighty":-6.624282,"marketCap":1528981338},{"date":"2026-06-05","current":-5.841412,"twenty":-7.647141,"median":-7.181588,"eighty":-6.506459,"marketCap":1373251758},{"date":"2026-06-12","current":-5.592674,"twenty":-7.644267,"median":-7.103996,"eighty":-6.310202,"marketCap":1314776223},{"date":"2026-06-18","current":-5.608384,"twenty":-7.605184,"median":-7.036462,"eighty":-6.158347,"marketCap":1318469415},{"date":"2026-06-26","current":-5.909488,"twenty":-7.595413,"median":-6.974676,"eighty":-5.98699,"marketCap":1389255588},{"date":"2026-07-02","current":-7.092956,"twenty":-7.5092,"median":-6.96318,"eighty":-6.007936,"marketCap":1667476025},{"date":"2026-07-10","current":-8.059107,"twenty":-7.645417,"median":-7.006288,"eighty":-6.078901,"marketCap":1894607311},{"date":"2026-07-17","current":-7.917719,"twenty":-7.67473,"median":-7.092956,"eighty":-6.150138,"marketCap":1861368586},{"date":"2026-07-24","current":-7.637561,"twenty":-7.776537,"median":-7.12986,"eighty":-6.183485,"marketCap":1795506668},{"date":"2026-07-31","current":-7.648035,"twenty":-7.738833,"median":-7.190209,"eighty":-6.195797,"marketCap":1797968796},{"date":"2026-08-07","current":-7.82346,"twenty":-7.815082,"median":-7.208161,"eighty":-6.219919,"marketCap":1839209436},{"date":"2026-08-14","current":-7.218207,"twenty":-7.815082,"median":-7.209243,"eighty":-6.276357,"marketCap":1897132498},{"date":"2026-08-21","current":-7.119553,"twenty":-7.785196,"median":-7.218207,"eighty":-6.321676,"marketCap":1871203580},{"date":"2026-08-28","current":-7.187671,"twenty":-7.738833,"median":-7.209243,"eighty":-6.354091,"marketCap":1889106881},{"date":"2026-09-04","current":-6.576954,"twenty":-7.707949,"median":-7.198831,"eighty":-6.380999,"marketCap":1728594532},{"date":"2026-09-11","current":-6.30448,"twenty":-7.706597,"median":-7.187671,"eighty":-6.346489,"marketCap":1656981329}],"updateTime":1789231803087},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMRA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1112635870","title":"Damora Therapeutics啓動Dmr-001治療突變CALR驅動型原發性血小板增多症與骨髓纖維化的Clarity-101 1/1B期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1112635870","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112635870?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 20:01","pubTimestamp":1785931269,"startTime":"0","endTime":"0","summary":"Damora Therapeutics正式启动一项名为Clarity-101的1/1B期临床试验,旨在评估其候选药物Dmr-001在突变型钙网蛋白驱动的原发性血小板增多症及骨髓纤维化患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654901371","title":"美國研究綜述-黑石集團、哈特福德保險公司、澤夫拉治療公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2654901371","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654901371?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 16:57","pubTimestamp":1785142662,"startTime":"0","endTime":"0","summary":"美国研究综述-黑石集团、哈特福德保险公司、泽夫拉治疗公司路透7月27日-周一,华尔街证券分析师下调了对包括黑石集团、哈特福德保险公司和泽夫拉治疗公司等数家在美国上市企业的评级和目标股价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4T43T0KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBC","AAPL","AMAL","CYH","GM","AGIO","CATY","PRVT","BWXT","HIG","CPF","DMRA","FHB","BY","AAPY","BBRE","FRBA","XAR","FMBH","F","BAH","FTAI","FTNT","HON","HWM","ITA","AXP","FCNCA","IXN","CLF","DLR","AAPD","BANR","BAX","FVCB","UTES","CHTR","CEG","FISI","AAL","CELC","ARLO","BAM","CUBI","JRE","BX","SRCE","FLG","CDRE","CRED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105165649","title":"傑富瑞首次覆蓋Damora Therapeutics,給予買入評級,目標價50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105165649","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105165649?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 14:03","pubTimestamp":1785132188,"startTime":"0","endTime":"0","summary":"杰富瑞(Jefferies)近日对Damora Therapeutics(重组前)启动覆盖研究,给予其“买入”评级,并将目标股价设定为50美元。这一举措凸显了市场对该公司发展前景的乐观预期,分析师认为其具备显著的成长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635995937","title":"美國研究綜述-思科、DTE能源、美滿科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2635995937","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635995937?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 15:25","pubTimestamp":1778743532,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、DTE能源、美满科技路透5月14日 - 周四,华尔街证券分析师调整了多家在美国上市公司的评级和目标股价,其中包括思科、DTE能源和美满科技。股票条目按字母顺序排列。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4S41R0NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STAA","KRMN","DMRA","LU1989764748.USD","MOH","USFD","CMS","LU1074936037.SGD","XEL","LU0661504455.SGD","TNGX","WY","GSHD","ARMK","NHI","DTE","DOCS","USPH","LU2023251221.USD","IE00BFTCPJ56.SGD","AMGN","ABBV","IE00BSNM7G36.USD","LU0868494708.USD","ARVN","MRVL","HLIO","AEE","CAKE","DT","LU1244550221.USD","LU1093756168.USD","CMP","LU0234570918.USD","LU0444971666.USD","MAIN","VSH","WEC","JACK","EYE","LU0054578231.USD","CSCL","MIRM","LU1084165304.USD","MRVU","MVLL","TXRH","BK4606","CSCO","CSCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151744301","title":"Galecto Inc旗下Damora計劃於2026年中提交DMR-001新藥臨床試驗申請 概念驗證數據預計2027年中公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1151744301","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151744301?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 20:07","pubTimestamp":1773058034,"startTime":"0","endTime":"0","summary":"生物技术公司Galecto Inc.近日披露其子公司Damora的最新研发进展。根据规划,Damora拟于2026年中期向监管机构提交DMR-001的新药临床试验申请或临床试验授权,该时间表标志着其在纤维化疾病治疗领域的重要里程碑。与此同时,针对DMR-001的概念验证关键数据集预计将在2027年中期揭晓。此次进展凸显了Galecto Inc.通过Damora平台深化其在创新疗法领域的战略布局。若后续研究顺利推进,DMR-001有望为特定纤维化疾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMRA","GLTO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}